期刊文献+

ECRG4在甲状腺乳头状癌组织中表达水平的研究

Expression levels of ECRG4 gene in thyroid papillary carcinoma tissues
原文传递
导出
摘要 目的研究甲状腺乳头状癌组织中ECRG4基因的表达水平,及ECRG4在甲状腺乳头状癌中的作用。方法收取甲状腺乳头状癌组织30例作为病例组,选取相对应的20例正常甲状腺组织作为对照组,通过实时荧光定量PCR法(QRT-PCR)以及免疫组织化学法,检测ECRG4基因及其蛋白在甲状腺组织中的表达情况。结果 QRT-PCR检测结果显示,ECRG4 m RNA在甲状腺乳头状癌中呈现高表达,其表达水平明显高于对照组(P<0.01);免疫组织化学结果也显示,甲状腺乳头状癌中ECRG4蛋白呈现出高表达,显著高于对照组(P<0.01)。结论甲状腺乳头状癌组织中ECRG4基因及其蛋白呈现高表达,ECRG4在甲状腺乳头状癌中可能为一个促癌基因,其在甲状腺癌的发生及发展过程中起着重要作用。 Objective To study expression levels of ECRG4 gene in thyroid papillary carcinoma tissues and explore the role in thyroid papillary carcinoma. Methods The thyroid papillary carcinoma tissues of 30 cases were collected and taken as the case group, normal thyroid tissues of 20 cases were selected as control group. QRT- PCR and immune histochemical methods were adopted to detect the ECRG4 gene expression levels in the thyroid tissues. Results The results of QRT- PCR detection showed that the ECRG4 expression levels were up-regulated in thyroid papillary carcinoma tissues, which was significantly higher than that of the control group (P〈 0.01);immunohistochemical results also confirmed that the ECRG4 protein expression level in thyroid papillary carcinoma tissues were enhanced significantly than that of the control group (P〈 0.01). Conclusion The expression levels of ECRG4 gene in hyroid papillary carcinoma tissues were up-regulated, so ECRG4 might be an oncogene in thyroid papillary carcinoma, it maybe play an important role in tumor occurrence and development.
出处 《中国热带医学》 CAS 2014年第9期1042-1044,共3页 China Tropical Medicine
基金 国家大学生创新项目(No.201310350015) 浙江省自然科学基金(No.Y2100248) 浙江省科技厅项目(No.2009C33155) 浙江省卫生厅项目(No.2009A218 2014KYA230) 台州市科技局项目(No.102KY15) 浙江省中医药管理局项目(No.2011ZA113)
关键词 食管癌相关基因4 甲状腺乳头状癌 促癌基因 ECRG4 Thyroid papillary carcinoma Oncogene
  • 相关文献

参考文献8

  • 1Elisei R,Molinaro E,Agate L,et al. Are the clinical and pathological fea- tures of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to an- swer this question [J]. J Clin Endocrinol Metab, 2010, 95(4):1516- 1527.
  • 2Li LW ,Yu XY, Yang Y, et al. Expression of esophageal cancer related gene 4 (ECRG4). a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo [J]. Int. J.Cancer. 2009, 125:1505-1513.
  • 3Aschebrook-Kilfoy B,Ward MH, Sabra MM, et al. Thyroid cancer in-cidence patterns in the United States by histologic type. 1992-2006 [J]. Thyroid, 2011, 21(2):125-134.
  • 4石曦雯,金贺,罗卫民.核基质结合因子SAFB1在甲状腺乳头状癌中的表达及意义[J].中国热带医学,2014,14(2):145-147. 被引量:3
  • 5魏杨辉,黄耀.P-Cadherin在甲状腺乳头状癌患者外周血中的表达[J].中国热带医学,2009,9(9):1701-1702. 被引量:4
  • 6王勇,施俊义.CYFRA21-1在甲状腺乳头状癌转移中的意义[J].中国热带医学,2010,10(10):1244-1245. 被引量:1
  • 7Xu T, Xiao D, Zhang X. ECRG4 inhibits growth and invasiveness of squamous cell carcinoma of the head and neck in vitro and in vivo [J]. Oncol Lett, 2015, 5(6):1921-1926.
  • 8Li I,W, Li YY, Li XY,et al. A novel tumor suppressor gene ECRG4 in-teracts directly with TMPRSSllA (ECRG1) to inhibit cancer cell growth in esophageal carcinoma [J]. BMC Cancer, 2011, 11 ( 1 ):52-58.

二级参考文献26

  • 1Hommura F,Furuuchi K,Yanmazaki K,et al . Increased expression of β-catenin predicts better prognosis in nonsmall cell lung carcinomas [J ]. Cancer, 2002,94(3 ) : 752-758.
  • 2Han AC,Soler AP,Tang CK,et al . Nuclear localization of E-cadherin express in Merkdel cell carcinoma [J] . Arch Pathol Lab Med,2000,124(8) :1147-1151.
  • 3Shirahama S,Furukawa F,Wakita H,et al . E-and P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer[J]. J Dermatol Sci, 1996,13( 1 ):30-36.
  • 4Lorenzo Lo Muzio,Giuseppina Campisi,Antonio Farina,et al . P- cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistoechemical study[J ]. BMC Cancer, 2005,5:63-.
  • 5Veerle Van Marck,Christophe Stove,Karolien Van Den Bossche,et al. P-cadherin Promotes Cell-Cell Adhesion and Counteracts Invasion in Human Melanoma[J]. Cancer Res 2005; 65 : ( 19 ).
  • 6Angst B,Marcozzi C,Magee A. The cadherin superfamily:diversity in form and function[J].J Cell Sci,2001,114(4) :629-641.
  • 7Giovanella L,Ceriani L,Ghelfo A,et al . Circulating cytokeratin 19 fragments in patients with benign nodules and carcinomas of the thyroid gland [ J ]. Int J Biol Markers, 2008,23 ( 1 ) : 54-57.
  • 8Marrakchi R, Ouerhani S, Benammar S, et al. Detection of cytokeratin 19 mRNA and CYFRA 21-1 (cytokeratin 19 fragments) in blood of Tunisian women with breast cancer [J ] . Int J B iol Markers, 2008,23 (4):238-243.
  • 9Koh JM,Kim ES,Ryu JS,et al . Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 1311 whole-body scan: comparative study [J] . Clin Endocrinol (Oxf),2003,58(4):421-427.
  • 10Baskin HJ . Detection of recurrent papillary thyroid carcinoma by thyroglobulin assessment in the needle washout after fine-needle aspiration of suspicious lymph nodes [J] . Thyroid,2004,14 ( 11 ) : 959-963.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部